Urgent window

Prescription Drug Overdose: Data-Driven Prevention Initiative (DDPI) deadline 2016

The current listed application deadline is May 27, 2016. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.

Agency
Centers for Disease Control - NCIPC
Award range
$250,000 to $750,000
Total funding
$21,000,000
Funding instrument
Cooperative Agreement
CFDA / ALN
93.136
Cost share
No

Deadline Status

This deadline has passed

Review the full grant record for updated cycles, archived guidance, and adjacent opportunities.

Quick facts

Opportunity number
CDC-RFA-CE16-1606
Last updated
May 3, 2016
Expected awards
16

Deadline summary

The purpose of this funding is to advance and evaluate state-level prevention for opioid overuse, misuse, abuse, and overdose. The FOA advances a two-tiered strategy to allow for the fact that the needs of states vary considerably. Some states need support to build their ability to collect, analyze, and apply data and develop a strategy to combat the epidemic. These states may apply for the Planning and Data (base) component alone. Other states need resources and support to implement a comprehen...

Date note

Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.

Key dates

Posted
March 25, 2016
Deadline
May 27, 2016

Before you apply

Confirm the official submission path and any portal requirements.
Review date notes carefully because this opportunity includes deadline-specific guidance.
Validate fit against the listed eligibility groups before investing drafting time.
This program expects about 16 awards, which can help frame competitiveness.

Eligibility snapshot

00State health departments or their bona fide agents. States receiving funding under Prescription Drug Overdose: Prevention for States (CE15-1501) or Prescription Drug Overdose: Boost for State Prevention (CE14-1404) are not eligible to receive funding under this FOA.

State health departments or their bona fide agents. States receiving funding under Prescription Drug Overdose: Prevention for States (CE15-1501) or Prescription Drug Overdose: Boost for State Prevention (CE14-1404) are not eligible to receive funding under this FOA.